chrisvoncsefalvay/vaers-outcomes huggingface dataset:
With the second dose I experienced itching and what it feels like a swollen mass on my left arm. I could push it and it would move around my arm. Like a little ball. It was hot to the touch. I also developed cellulitis on my left arm but not at the injection site, lower (medium anterior lateral part of my left arm).  I decided to go to the ER to get it checked and they told me it was cellulitis. They prescribed me Augmentin and it did the trick, 48 hrs after starting the Augmentin it was much better and now it is all gone. The little moveable lump in my arm is much smaller but I can still feel it if I press it.
Trace edema at forearm area, blood pressure increased for 2 days, dizziness, redness at site.
haven't felt great since first vaccination; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (haven't felt great since first vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Aug-2021, the patient experienced MALAISE (haven't felt great since first vaccination). At the time of the report, MALAISE (haven't felt great since first vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitent drugs were provided.  No Treatment drugs were provided.
Feverish, chills, nausea, diarrhea, dull headedness, headache, deep fatigue, lethargy, injection site pain Feverish symptoms/chills broke late afternoon on October 9th. Some chill briefly overnight, but it passed.
Early in May,  began having sensations on left side of middle torso that felt like a herpes zoster breakout was coming.  There has been no blisters or lesions develop, but the neuralgia continues with burning, tingling, numbness, discomfort. Has continued for about a month.  Plan to see my PCP to possibly start on antivirals.
Within 5 minutes of injection I have tingling in my lips and tongue, still present now.
both past due for dose 2 of Shingrix./ Patient 2 dose 1 : 15months ago; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 15 months before the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not applicable for this report. The age group was not reported but was selected as an adult as per vaccine indication. The patient was past due for 2nd dose of Shingrix. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. No other details were reported. The reporter did not feel comfortable providing patient information. The reporter consented to follow up. This case is linked to the case US2021071588, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021071588:same reporter
3 weeks after injection, Pt still has a fever of over 100 or more, suffering from extreme fatigue, loss of appetite since the second shot now losing weight, has experienced some increase in the symptoms of his schizophrenia, night sweats, exhaustion
chills and fever called Health Point and asked if I could take tyonal. took 1 6 hours later took another. Ever sense I can not do anything without becoming short of breath and very tired. This started after the first day and is still happening today 03/13/2021. Feel like I cannot take a deep breath or walk for any length of time.
Positive for COVID 1 week after the 1st dose of moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive for COVID 1 week after the 1st dose of moderna vaccine) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Positive for COVID 1 week after the 1st dose of moderna vaccine). At the time of the report, SARS-COV-2 TEST POSITIVE (Positive for COVID 1 week after the 1st dose of moderna vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, SARS-CoV-2 test positive: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided.  No treatment medication were provided.
Soreness from the first night but 3 days later I noticed a large rash up my upper left arm around the injection sight. It is similar to a rash I got from a pneumonia vaccine last fall but I haven?t ever gotten a rash form a flu shot.
Patient came to a follow up appointment one week after she was given her administration. She stated that she had swelling, redness and tenderness from the injection site down to almost her elbow, and swelling under the arm. She stated this occurred the next morning. The swelling, redness and tenderness has gone away since but there is a quarter sized lump at administration site. There was no treatment given and patient was asked to call if the site changes or worsens or any other symptoms starts up.
No adverse event. Pt. <12yrs of age and received Pfizer Covid vaccine. Parent's consent given and was at chairside at time of incident.
Patient was under the age of 18 when they received the COVID19 (Moderna) Vaccine
Pregnant woman recieved Fluzone QIV with no reported adverse event; Initial information was received on 01-Sep-2021 regarding an unsolicited valid non-serious case from other health professional.  This case involves a 26-year-old pregnant female patient who was vaccinated with INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] on 09-Feb-2021 (exposure during pregnancy).  Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported Pregnant woman received Fluzone QIV with no reported adverse event occurred at unknown gestation period.  The date of last menstrual period was not reported.  The estimated due date is 02-Oct-2021.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient's past medical treatment(s), vaccination(s) concomitant medications and family history were not provided.  On 09-Feb-2021, the patient received a dose 1 of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number: UT7325JA; expiry date: 30-Jun-2022; form: suspension for injection) via intramuscular route in unknown administration site for prophylactic vaccination.  It was the case of vaccine exposure during pregnancy (same day latency).  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were laboratory data/results available.  At time of reporting, the outcome was unknown for the reported event.  Additionally, at time of reporting, the outcome of the pregnancy was unknown.
not received the second dose yet; This case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date in 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The nurse reported that a patient who received the first dose of Shingrix and had not received the second dose till the time of reporting, which led to incomplete course of vaccination. The reporter consented to follow up via email. The VAERS details reported for 1st dose of shingrix.
ErythemaMultiform Pop can size redness at injection  Grown in size pain, warmth
no adverse effects; Improperly stored administered doses; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided.  On 21-MAY-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # R034394, expiration date 27-NOV-2020; dose and route unknown) for prophylaxis. The vaccine was exposed to temperature excursion from -14 to 10 degrees Celsius (C) for 15 hours. Data logger involved. There was no previous temperature excursion. No adverse effects were reported.  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-1906USA000180:
Severe diarrhea leading to a loss of 10 pounds over 24 hours. I went to an urgent care facility 36 hours after the diarrhea started and they sent me to the hospital emergency room for treatment. I was given 2 liters of fluids (lactated ringers & sodium chloride) and then sent home. The diarrhea finally stopped about 20 hours later.
I received my first Moderna inoculation 12/24/2020 in my left arm. Lot#039K20A. No problems to report. I received my 2nd Moderna vaccine (lot#029L20A) 01/21/2021 in my right arm and immediately the left injection site of 12/24/2020 began throbbing. By Friday (22nd) afternoon, I was feverish, achy all over like an influenza bug had gotten hold of me and I had to leave work early. Those symptoms subsided by Monday, 25th of January. To this day, my left arm is still painful, I cannot raise my left arm above my shoulder without pain, and every time I use my left hand, the left bicep muscle is painful. EIGHT months after my second inoculation, my left arm STILL HURTS.
Initial report received on 05 October 2011 from the investigator under the reference number M5A16. A case of pertussis disease in a four-year-old female subject was identified by the investigator based on review of data from the surveillance system database. The subject's vaccine history included 4 doses of DAPTACEL; lot number C2657AA received on 04 September 2007 and 29 October 2007, lot number C2607AA received on 03 January 2008, and lot number C2956AA received on 29 December 2008 (routes and sites of administration not reported). The subject developed cold-like symptoms and cough on 24 August 2011, approximately 31 months after the last dose. On 12 September 2011, the subject developed a paroxysmal cough with a whoop. The subject also experienced posttussive vomiting and sleep disturbance. Laboratory testing included positive PCR on 12 September 2011. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of azithromycin starting on 12 September 2011 for five days. The subject was not hospitalized. At the time of final contact on 15 September 2011, the subject's cough was still persisting. The duration of the cough was reported at that time as 23 days. According to the investigator, this case was epidemiologically linked to a laboratory confirmed case. Investigator causality assessment is not required as per protocol. Document held by sender: None.
Evening of 2/22 (5 days after 2nd Pfizer shot) I had onset of fast and erratic pulse (120+/min). I had a 10-yr history of paroxysmal atrial fibrillation and had a successful ablation about 4 yrs before this event. Being familiar with Afib symptoms, this even felt very different. I contacted my electrophysiologist, Dr. on 2/23 and on 2/24 Dr. after diagnosing an "atypical atrial flutter", performed a cardioversion at Hospital center restoring sinus rhythm (stable now for 7+ months). I did not initially connect the atrial flutter event to the 2nd Pfizer injection at the time (February 2021), but after reading much later about the very rare cardio problems in mostly younger males shortly after r
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 13-SEP-2014, the patient was vaccinated with PNEUMOVAX 23 intramuscular, expiration date 22-AUG-2014 (dose, strength, frequency and lot number were not reported). Secondary and concomitant therapies were not reported. On 13-SEP-2014, a dose of PNEUMOVAX 23 which was expired (on 22-AUG-2014) was inadvertently administered to patient. No adverse effects reported. Additional information has been requested.
since my second shot which was back in Nov I have been having headaches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date Nov2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1), for Covid-19 immunization. The following information was reported: HEADACHE (non-serious), outcome "not recovered", described as "since my second shot which was back in Nov I have been having headaches".  Additional information: The patient had received both dose of the Pfizer covid vaccine and ever since patient second shot which was back in Nov, patient have been having headaches all day everyday and it never was like this until after could this be a side-effect of the vaccine.  The lot number for bnt162b2 was not provided and will be requested during follow up.
A couple hours after receiving the vaccine my arm became more sore- more so than with any other vaccine I have ever had. At 2pm I became very tired and fell asleep for two hours. At 4pm I was unable to rest without any pain in my affected extremity. At 5:30pm I went to the grocery store and started to experience nausea and joint pain in my lower extremities. I went into the ER at 7pm because I was brought to tears with pain from my injection site when trying to change shirts. At this point I had a headache, nausea, joint pain, stomach aches, a fever (101.5), severe pain in my right arm, and a rash from my injection site across my chest and to my left upper arm.
21SEP96 930AM pt recv vax 2Pm gen urticaria;23SEP96 periorbital swelling;24SEP96 much better;
Stated with body aches and fever. Body aches became extreme on day 2 after shot. Day three after shot started with motion temors. I move in any way and my body starts to tremor. If I try to walk to far are do too much I shake so much I get dizzy and collapse. Bystanders stated it looked like I was having a seizure
My daughter rec'd the first HPV shot 03/16/08 and complained of soreness at injection site which  subsided within a couple of days.  She went for 2nd dose on 05/16/08 and her arm has not been the same since. She complains of muscle soreness and has a small bump at injection site to this day July 9, 2008.  She sometimes has difficulty lifting her arm up. I brought her to her MD and nurse practitioner told her to exercise the arm and said this is a normal to feel pain afterwards.  I feel this is from the HPV vaccine and consider it to be a consequence of that shot.  I will NOT allow her to get the 3rd dose.  It was recommended by the NP that she should probably get this third and final shot in her leg, because of the problem she had with her arm. I fear that if the same thing happens she will have problems walking if this shot was to be given in her leg, just as she had problems moving and lifting her arm. I feel this is directly related to the HPV vaccine because she never had a problem with her arm/ muscle before.
had SHINGRIX shot #1 about two years ago but never had SHINGRIX shot #2; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 2 year prior to the reporting).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: had SHINGRIX shot #1 about two years ago but never had SHINGRIX shot #2). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt date: 19-JUL-2023 The patient had Shingrix shot 1 about two years ago but never had Shingrix shot 2. (Prescriber was considering re-starting the series). Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination. The reporter consented to follow up.
5/20/15 Received inj that morning. That night began having: Fever (102) chills/headache/body aches/swelling at inj site/red site/warm site. Fever/headache/body aches resolved in about 24 hours. Inj site enlarged, then area resolved by 5/26/15.
6 pm rash discovered on lower portion of legs went to group health urgent care at 6:30 PM and rash spread to upper arms and back. Blood tests were given. Follow-up appt made for next day at 11:20 w/ Dr. who stated in patient summary "your rash looks very much like a reaction to the Tdap shot you got yesterday."
Shoulder Impairment Resulting from Vaccine Administration. Pain on left arm from vaccine site. Bursitis. Rotator cuff tear
I was very tired not feeling well; I was surprised to get a bad reaction from the booster; I was very tired not feeling well; I was surprised to get a bad reaction from the booster; Fever; Shivering; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 20Oct2021 (Lot number: FF8839) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), administration date: Mar2021, for Covid-19 immunization; Bnt162b2 (Dose 2), administration date: Apr2021, for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 20Oct2021, outcome "recovering", described as "Fever"; CHILLS (non-serious) with onset 20Oct2021, outcome "recovering", described as "Shivering"; FATIGUE (non-serious) with onset 21Oct2021, outcome "recovering", MALAISE (non-serious) with onset 21Oct2021, outcome "unknown" and all described as "I was very tired not feeling well; I was surprised to get a bad reaction from the booster". Therapeutic measures were taken as a result of pyrexia, chills.  Additional information included: Patient have had the two Pfizer shots back in March and April and this past Wednesday patient had the booster shot up until that point. Patient had no bad reactions from the shot but after patient received the booster shot that night, patient had a fever and was shivering and took Tylenol (Treatment) and drank lot of water and then the next day patient was very tired not feeling well but as of today patient felt like oneself but was surprised to get a bad reaction from the booster since, patient didn't have any bad reaction from the first and the second shot. Patient also clarified that the bad reaction was from the booster shot but not from the two previous shot. Follow-up attempts completed. No further information expected.  No follow-up attempts are possible. No further information is expected.
pain and aches; nausea; soreness at the injection site; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (pain and aches), NAUSEA (nausea) and VACCINATION SITE PAIN (soreness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (pain and aches), NAUSEA (nausea) and VACCINATION SITE PAIN (soreness at the injection site). At the time of the report, MYALGIA (pain and aches), NAUSEA (nausea) and VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.  No concomitant medications provided.
This spontaneous report was received from a Nurse, concerning a 3 year old patient of unknown gender with multiple medical conditions including cerebral palsy, asthma and tympanic ear membrane disorder (without cochlear implant). The patient had history of weak antibody response to pneumococcal vaccine. On unspecified dates in the past, the patient received four doses of PREVNAR 13 according to PREVNAR 13 schedule. On an unknown date (reported as "after the fourth dose of PREVNAR 13 two years ago"), the patient received a dose of PNEUMOVAX 23 for prophylaxis. Other suspect therapies included PREVNAR 13 for an unknown indication (dose, route of administration, anatomical location, lot numbers and expiration dates were not reported). On an unknown date, the patient developed weak antibody response to pneumococcal vaccine (vaccination failure), however, the nurse could not specify if it applied for both suspect therapies or only for one of the products. The outcome of vaccination failure and the causal relationship between the event and the suspect vaccines were not reported.